Empresa Hubei Hongyuan Pharmaceutical Technology Co., Ltd.
Acciones
301246
CNE100005ZB9
Farmacéuticos
Precio de cierre
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
15,5 CNY | -0,45 % | -4,32 % | -40,34 % |
Resumen de negocios
Número de empleados: 2 075
Ventas por actividad
CNY en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Raw Materials and Pharmaceuticals Intermediates
44,7
%
| 946 | 45,9 % | 919 | 44,7 % | -2,85 % |
Lithium Battery Material
38,1
%
| 738 | 35,7 % | 784 | 38,1 % | +6,23 % |
Organic Chemical Raw Materials
10,7
%
| 263 | 12,8 % | 220 | 10,7 % | -16,50 % |
Pharmaceutical Preparations
4,5
%
| 82 | 4,0 % | 92 | 4,5 % | +12,87 % |
Others
1,9
%
| 34 | 1,7 % | 39 | 1,9 % | +14,67 % |
Ventas por región
CNY en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
China
85,3
%
| 1 677 | 81,3 % | 1 753 | 85,3 % | +4,48 % |
Overseas
14,7
%
| 386 | 18,7 % | 302 | 14,7 % | -21,75 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Shuang Xi Xu
CEO | Chief Executive Officer | 58 | - |
Gao Liang Lei
CHM | Chairman | 59 | - |
Ke Feng Zeng
DFI | Director of Finance/CFO | 39 | - |
Xiao Hui Li
CTO | Chief Tech/Sci/R&D Officer | 39 | - |
Xiao Liu Duan
BRD | Director/Board Member | 59 | - |
Ying Yao
BRD | Director/Board Member | 37 | - |
Zhan Liang Liu
BRD | Director/Board Member | 58 | - |
Zhi Hua Deng
BRD | Director/Board Member | 54 | - |
Si Yuan Cheng
BRD | Director/Board Member | 51 | - |
Dan Yin
IRC | Investor Relations Contact | 36 | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Qing Xie
BRD | Director/Board Member | 61 | - |
Si Yuan Cheng
BRD | Director/Board Member | 51 | - |
Zhi Hua Deng
BRD | Director/Board Member | 54 | - |
Guo Ping Yin
FOU | Founder | 64 | 21/01/02 |
Xiao Hui Yan
BRD | Director/Board Member | 53 | - |
Shuang Xi Xu
CEO | Chief Executive Officer | 58 | - |
Zhan Liang Liu
BRD | Director/Board Member | 58 | - |
Gao Liang Lei
CHM | Chairman | 59 | - |
Xiao Liu Duan
BRD | Director/Board Member | 59 | - |
Lin Tao Wang
BRD | Director/Board Member | 54 | - |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 400 006 800 | 149 298 058 ( 37,32 %) | 0 | 37,32 % |
Información de la empresa
Hubei Hongyuan Pharmaceutical Technology Co., Ltd.
Economic Development Zone Fengshan Town
438600, Huanggang
+86 71 3507 2024
http://www.hbhypharm.comVentas por actividad
Ventas por región
Varia. 1 de ene. | Capi. | |
---|---|---|
-40,34 % | 856 M | |
+38,51 % | 727 mil M | |
+33,05 % | 599 mil M | |
-6,23 % | 354 mil M | |
+18,78 % | 328 mil M | |
+1,35 % | 277 mil M | |
+16,00 % | 243 mil M | |
+8,09 % | 205 mil M | |
-5,77 % | 203 mil M | |
+6,19 % | 164 mil M |
- Bolsa de valores
- Acciones
- Acción 301246
- Empresa Hubei Hongyuan Pharmaceutical Technology Co., Ltd.